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Ethanol Embolotherapy of Pelvic
Arteriovenous Malformations: 
an Initial Experience
Objective: We retrospectively assessed the results of performing ethanol
embolization for pelvis arteriovenous malformations (AVMs).
Materials and Methods: During the past 10 years, eight patients (8 females,
age range: 27 52 years) with AVMs in the pelvic wall (n = 3) and uterus (n = 5)
underwent staged ethanol embolizations (range: 1 5, mean: 2.5) under general
anesthesia. Ethanol embolization was performed by the use of the transcatheter
and/or direct puncture techniques. Clinical follow-up was performed for all of the
patients, and imaging follow-up was available for seven patients. The therapeutic
outcomes were established by evaluating the clinical outcome of the signs and
symptoms, as well as the degree of devascularization observed on post-proce-
dural angiography.
Results: During the 20 sessions of ethanol embolization, the solitary transarte-
rial approach was used 14 times, the transvenous approach was used three
times and direct puncture was used once. For two patients, the transarterial and
transvenous or direct puncture approaches were used together in one session.
For four patients, ethanol and coils were used as embolic agents, and n-butyl
cyanoacrylate (NBCA) and ethanol were used in one patient. Seven (88%) of
eight patients were cured of their AVMs and one patient (12%) displayed
improvement. Major complications were seen in two patients (25%).
Conclusion: Ethanol embolization is effective for the treatment of pelvic arteri-
ovenous malformations, though there is a chance of a major complication.
mong the many kinds of arteriovenous malformations (AVMs), the pelvis
AVM is especially difficult to diagnose because of its scarcity, vague
symptoms and its deep location. The pelvis AVM is a potentially life-
threatening disease due to the potential for spontaneous hemorrhage and congestive
heart failure (1).
Surgical treatment, the classic method for treating vascular malformations, including
pelvic AVMs, either by ligation of the afferent arteries or by attempted excisions, has
not usually been successful as surgical eradication of the nidus of an AVM is rarely
possible. Further, this is often followed by recurrence and progression of the disease
(2, 3). Selective embolization can obliterate AVMs and it is increasingly being
employed for the treatment of pelvic AVMs. Although intra-arterial embolization of
AVMs by using particulate materials can provide symptomatic relief, the lesions recur
in most cases because the nidus is not permanently occluded (4, 5). Superselective
catheterization or direct puncture of the nidus and the use of ethanol as a permanent
embolic agent have shown good clinical and radiological implications for improving
the treatment of AVMs, with an acceptable risk of morbidity (5, 6).
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AThe purpose of this study is to assess retrospectively the
results of performing ethanol embolization of pelvis
AVMs.
MATERIALS AND METHODS
Patients
We obtained institutional review board approval at our
hospital for conducting a retrospective review of patient
medical and imaging records. Written consent for the
procedure was obtained from all the patients after a discus-
sion about the advantages and risks of the procedure. From
November 1996 to March 2006, we performed staged
ethanol embolization on eight female patients with AVMs
in the pelvic wall and uterus. The mean age of the patients
was 35.9 years (age range: 27 52 years). One patient had
a history 10 years prior of a previous dilatation and
curettage following a recurrent abortion, and this was
suggestive of a traumatic AVM. The AVMs in seven
patients were considered to be of a congenital origin. For
all the patients except one, who had previously undergone
unsuccessful embolizations with microcoils and particles at
another institution, ethanol embolization was decided to
be used as a primary treatment by the consensus of
gynecologic surgeons, vascular surgeons and interventional
radiologists after conducting a full review of the findings
from the clinical and radiological examinations of the
patients. The patients displayed various signs and
symptoms: vaginal bleeding (3 of 8 patients) and pain (2 of
8 patients) were the most common signs and symptoms.
One patient had cardiomegaly and a recurrent abortion
and another patient had dysmenorrhea. In one patient, an
incidental pelvic mass was detected on routine pelvic
ultrasonography. Five patients had AVMs in the uterus and
three had AVMs in the pelvic wall. Imaging studies includ-
ing the use of Doppler ultrasound (US), computed
tomography (CT) or CT angiography, magnetic resonance
imaging (MRI) with gadolinium contrast or the gradient
echo sequence, and technetium 99m-labeled red blood cell
scintigraphy were first used for making a diagnosis, and
then selective angiography was performed to define
accurately the feeding arteries, draining veins and nidus of
the AVMs.
Procedure
All of the procedures were performed under general
anesthesia. A Swan-Ganz catheter (Baxter Healthcare,
Irvine, CA) was inserted for the pulmonary arterial
monitoring that preceded the embolization procedure. If
an elevation of the mean pulmonary arterial pressure (> 25
mmHg) was detected, then nitroglycerine was adminis-
tered as a bolus injection (50 100  g) and then it was
continuously infused at 0.3 3.0 ( g kg
1)/min through the
Swan-Ganz catheter until the mean pulmonary artery
pressure reached normal levels.
Staged ethanol embolization was performed to embolize
all or part of the nidus. The routes for gaining vascular
access to the nidus were chosen after performance of initial
angiography. Transarterial catheterization, transvenous
catheterization by using a coaxial microcatheter for the
superselection of the nidus and/or direct percutaneous
puncture were required to reach the nidus itself and not
the vascular feeders for embolization (5). An additional
balloon catheter was used to reduce proximal flow to the
nidus when ethanol was injected in two sessions for two
patients. Pure (99.9%) ethanol was used as an embolic
agent. The amount of ethanol used was based on the
amount of contrast medium required to fill the AVM nidus
without opacifying the normal vessels. During the 20
sessions of ethanol embolization, the solitary transarterial
approach was used 14 times, the transvenous approach
was used three times and direct puncture was used once. In
two patients, the transarterial and transvenous or direct
puncture approaches were used together in one session
(Fig. 2). In 6 sessions of four cases with multiple feeders
and a dominant draining vein, coils (Nester coil; Cook,
Bloomington, IN) were used to reduce the amount of
required ethanol in the nidus of the AVM and to stabilize
the thrombosis in the dilated outflow vein as previously
reported (5). In one case, n-butyl cyanoacrylate (NBCA)
was additionally used with ethanol to stop vaginal
bleeding.
To control the localized soft tissue swelling in the pelvic
wall and uterus, a corticosteroid (0.1 mg/kg dexametha-
sone, Dexamethasone, Yuhan, Seoul, Korea), was given
immediately before the procedure and then every eight
hours intravenously by bolus injection while the patients
were in the hospital (5, 7). After the patients were
discharged, prednisolone (Solondo; Yuhan) was adminis-
tered orally at 1 mg kg
1)/d (maximum daily dose, 15 mg)
in three divided doses, which was tapered over a 1-week
period. Any hemoglobinuria that occurred during the
procedure was managed by means of hydration with an
intravenously administered crystalloid solution. To
evaluate renal function, serum creatinine and urea levels
were measured at least once during the hospital stay.
Evaluation of the Clinical Data and Follow-up Results
Two radiologists working in consensus analyzed the
therapeutic responses to ethanol embolization by compar-
ing the degree of AVM devascularization between the
baseline angiography and final angiography (i.e., 100%,
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Fig. 1. 34-year-old woman (patient 1) with right pelvic wall arteri-
ovenous malformations. 
A-C. Posteroanterior pelvic angiogram shows arteriovenous
malformations with multiple feeding arteries from right internal and
external iliac arteries, nidus (arrows) and large draining vein
(arrowhead) to right ovarian vein. 
D, E. After three sessions of ethanol treatment and coil emboliza-
tions, arterial and venous phases of posteroanterior angiogram
show complete obliteration of arteriovenous malformations. 
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Fig. 2. 38-year-old woman (patient 8) with uterine arteriovenous
malformations that caused massive vaginal bleeding. 
A-C. Pretreatment posteroanterior pelvic angiogram shows large
arteriovenous malformations in uterus with dilated draining veins. 
D. Two sessions of transarterial approach with using ethanol were
not effective for managing vaginal bleeding. One session of direct
puncture of uterine arteriovenous malformations and NBCA (n-
butyl cyanoacrylate) embolization was performed to stop the
vaginal bleeding. 
E. Final posteroanterior pelvic angiogram shows complete oblitera-
tion of arteriovenous malformations. 
CD
E76 99%, 50 75%, or < 50%). The clinical outcome of
the signs and symptoms (complete or partial resolution, no
change, or aggravation) was evaluated at the congenital
vascular malformation clinic by a consensus of two
surgeons and one interventional radiologist. Cure was
defined as complete resolution of the signs and symptoms,
and 100% devascularization of the AVMs being observed
by angiography. Improvement was defined as complete or
partial resolution of the signs and symptoms, and 50 99%
devascularization of the AVMs observed on angiography.
No change was defined as partial resolution or no change
of the signs and symptoms, and less than 50% devascular-
ization of the AVMs observed on angiography. Cure and
improvement were considered effective therapeutic
outcomes of ethanol embolization.
Complications were classified as being either major or
minor. The major complications included death, permanent
adverse sequelae, the required performance of major
therapy and prolonged hospitalization (> 48 hours). Minor
complications included any nonpermanent adverse
sequelae. The patients were physically and neurologically
examined before and after embolization to assess the
complications. When major complications were observed,
we then reviewed the angiograms again to find the possible
causes of the major complications.
Periodic (1 6 months) follow-up evaluation was
performed based on the use of color Doppler US,
technetium 99m-labeled red blood cell scintigraphy, CT or
MRI during the multi-session therapy. Follow-up imaging
(range: 14 82 months, median: 29 months) was available
from the last treatment session for seven patients.
RESULTS
During the 20 sessions of ethanol embolizations (range:
1 5, mean 2.5), the amount of ethanol used ranged from 8
to 59 ml (mean: 30.3 ml) in a single embolization session.
None of the patients experienced ethanol toxicity.
Seven (87.5%) patients were cured and one patient
(12.5%) had improvement of the AVMs (Fig. 1). Ethanol
embolization was considered an effective treatment for all
the cases. Except for one patient, the AVMs were totally
devascularized, as was demonstrated on the follow-up
imaging studies. One patient who achieved improvement
did not want further treatment. All the patients showed
complete or partial resolution of their clinical symptoms
and signs.
Two patients (25%) experienced major complications.
One patient complained of urinary urgency after complete
embolization of the pelvic AVMs. Focal bladder necrosis
was confirmed upon cystoscopy and this healed after two
weeks of conservative management. Another patient
developed permanent ovarian insufficiency as a chronic
complication after four sessions of ethanol embolization
for treatment of uterine AVMs. Hormone replacement
therapy was needed to improve the symptoms of ovarian
insufficiency.
DISCUSSION
Pelvic AVMs can have either a congenital or an acquired
etiology. Congenital AVMs are the result of anomalous
differentiation or developmental arrest in the primitive
capillary plexus during the 4th and 10th weeks of
embryonic life, and they usually present at a young age.
They tend to extend to the surrounding tissues beyond the
uterus (6, 8 10). Acquired AVMs may develop due to
dilatation and curettage (D & C), therapeutic abortion,
surgery, cancer and gestational trophoblastic disease
(GTD). As a distinction, acquired AVMs are usually
confined to the uterus and they tend to have single or
bilateral feeding arteries, no blood supply from the
extrauterine arteries, the lack of a nidus and a single
draining vein (10). Some investigators have suggested that
acquired uterine AVMs are multiple small arteriovenous
fistulae between the intramural arterial branches and the
myometrial venous plexus, and they appear as a vascular
tangle that mimics the congenital AVMs (11 13).
Surgical treatment of pelvic AVMs, either by ligation of
the afferent arteries or by an attempted excision, has not
usually been successful as surgical eradication of the nidus
of an AVM is rarely possible and surgery is often followed
by recurrence and progression of disease. Several investi-
gators agree that simple ligation of the feeding artery is not
effective since new collaterals rapidly develop to bypass
the ligated vessels and most of the cases of surgical
treatment reported in the literature have included a
hysterectomy (2, 3, 6).
Transcatheter arterial embolization for uterine AVMs
was originally used in the intraoperative setting to stop
bleeding in women suffering with congenital AVMs.
Especially in women that want to preserve their fertility,
transcatheter arterial embolization has been proposed as a
relatively safe technique (6). Several agents have been
used, and these have been associated with a few problems
such as recanalization and difficulty in controlling the level
of occlusion (5). In a series of pelvic AVMs that were
related to gestational trophoblastic disease, initial control
of uterine hemorrhage was achieved in 11 of 14 patients
with embolization that used PVA (polyvinyl alcohol)
particles (150 500  m): six patients required repeat
embolotherapy (14). In another study that mainly used
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recurrent bleeding (10).
The use of ethanol has shown good results for the
management of AVMs, and this technique has shown the
ability to induce protein denaturation of the endothelial
cells with subsequent vessel wall denudation and interrup-
tion, which results in the complete obliteration of the
vessel lumen rather than just simple obstruction (5, 15
17). However, there are several complications with the use
of ethanol for various mechanisms such as local tissue
injury (skin swelling, necrosis, peripheral nerve palsies),
renal tubular necrosis (renal insuffiency), thrombus
formation (thrombophlebitis, pulmonary embolism), and
pulmonary arterial spasm (systemic arterial hypotension,
cardiac arrhythmia, cardiopulmonary collapse) (5, 15). The
careful use of ethanol and routine monitoring of
pulmonary arterial pressure are required of the interven-
tional radiologist.
The use of ethanol has proved its efficacy in the manage-
ment of peripheral AVMs (5, 16, 18, 19). For treating
peripheral AVMs of 40 patients, ethanol embolization was
effective in 27 patients (68%), and only one patient
showed aggravation of their AVMs (5). In this study, seven
patients were cured and one patient experienced improve-
ment. To the best of our knowledge, this is the first series
that has treated pelvic AVMs with ethanol, and the results
are comparable with the previous studies that used other
embolic materials. Coils and NBCA were also used as
embolic agents in some treatment sessions (Fig. 2). These
were mainly used to reduce the total amount of ethanol.
As recommended previously, we tried not to exceed a
maximum volume of ethanol during sclerotherapy of over
0.5 1.0 mL/kg in every single session (19, 20).
We attempted as much as possible to perform emboliza-
tion by the transarterial approach. Yet, very tortuous
vascularity or the presence of adjacent major arterial
branches made it necessary to perform additional transve-
nous or percutaneous embolization (17). Some investiga-
tors have reported that arterial embolization was unneces-
sary because of the slow flow of the arterial system, which
is composed of multiple plexus-form arterial tributaries (2).
However, this transvenous technique may cause inadver-
tent occlusion of the normal venous drainage from
surrounding tissues with resultant venous hypertension and
deep vein thrombosis (21). The direct puncture technique
is easier and simpler to employ than the other techniques.
Other sclerosants such as coils or NBCA cannot be used by
this method, and extravasation may occur.
In this study, there were two major complications of
non-targeted embolization. One patient suffered from
urinary urgency that developed after the procedure. Focal
bladder necrosis was found by cystoscopy. The bladder
necrosis improved with conservative management.
Another 42-year-old patient experienced permanent
ovarian insufficiency. Ovarian failure occurs in 1 14% of
patients after they undergo uterine arterial embolization
for the management of symptomatic uterine fibroids. This
can be explained as ovarian failure is associated with a
reduced ovarian capacity in women over 40 years and by a
compromised blood supply via the utero-ovarian collateral
circulation after uterine arterial embolization (22, 23). In
order to prevent such an embolic complication, some
investigators have recommend confirming the patency of
the collateral artery before embolization and performing
the procedure as selectively as possible (24 26).
There are some limitations in this study. First, even
though our treatment results were good, the number of
cases was small. Second, in most cases we used ethanol
rather than another embolic agent such as NBCA. If we
had treated a larger number of pelvic AVMs, then a
comparative study with other embolic agents might have
been necessary. Finally, this study was insufficient for the
evaluation of such delicate issues as pregnancy after
ethanol sclerotherapy.
In conclusion, a pelvic AVM is a silent and dangerous
condition in some situations. Ethanol embolization is an
effective treatment for pelvic AVMs with a high cure rate
based on our experience. However, there is a chance of
major complications with the use of ethanol. It is
mandatory to perform long-term follow-up for patients and
to accumulate more experience with this technique to
lessen the complication rate.
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